“…The masses of WAT tend to differentiate and occupy body spaces in which their presence causes only limited functional problems (or where their mechanical/thermic buffering becomes an asset), and are correlated with the massive presence of intracellular fat depots and the presence, but also of interspersed cells or small groups of WAT cells within a number of organs and tissues, such as the muscle: intramuscular [753][754][755], pericardial [756], perivascular [757,758]; other specialized tissues, bone marrow [759,760], or mammary tissue [761]; as well as surrounding them for physical/thermal protection, nurture, and regulation: perigonadal [762,763], subcutaneous [764][765][766], perirenal [767], and mesenteric [768,769] adipose tissues. The location and close relationship with specific organs, sharing contact and direct metabolic and humoral-regulatory connections, result in a high level of sub-specialization in both cell composition, depot size, and metabolic activity [770][771][772]. There has been considerable discussion on the pathogenic significance of their gross excess of energy, which is finally converted into adipocyte depots in the form of defined WAT masses, and of groups of adipocytes interspersed with other tissue cells in organs and tissues.…”